T cell Vaccines Lab (Swadling UCL) 🧬👩🏽‍🔬
@tcellvaccineucl.bsky.social
230 followers 230 following 35 posts
Sometimes tweeting about T cells, Vaccines, Viruses, TCRs, Immunogen Design, AI, Viral Seq Evolution... PI: Leo Swadling @IIT_UCL 🍐 www.researchgate.net/profile/Leo-Swadling profiles.ucl.ac.uk/61477-leo-swadling
Posts Media Videos Starter Packs
Reposted by T cell Vaccines Lab (Swadling UCL) 🧬👩🏽‍🔬
yefis-immunology.bsky.social
👶✈️ Balancing caregiving and academic travel?

Join Dr. Laura Pallett for "The Dual Demands of Academic Travel and Caregiving"

🗓️ Sept 25 | 🕒15:00 CEST
🔗https://tinyurl.com/yefis2025-ia2

Hosted by the Improving Academia group of yEFIS
tcellvaccineucl.bsky.social
In vivo challenge after vaccination also showed strong protection for the i.n. administered vaccine, although protection wasn’t compared to the i.m. vaccine. Further evidence for targeting the local mucosa to facilitate protective immunity.
tcellvaccineucl.bsky.social
Another nice study illustrating that targeting responses to the nasal mucosa could be superior to systemic administration. The CAF09b adjuvant plus recombinant protein in an i.n. vaccine induced better nasal IgA and CD8 responses than i.m. mRNA.
tcellvaccineucl.bsky.social
Cool to see this upcoming phase 2 clinical trial for aerosolised vaccine formulations, with planned measurements of lung T cell responses
publications.ersnet.org/content/erjo...
#clinicaltrial #tcell #vaccineswork #immunology #vaccine
publications.ersnet.org
tcellvaccineucl.bsky.social
Lots of food for thought from these two studies.
1) It’s great to see comprehensive repertoire analysis being applied to clinical trial data
2) Could a bespoke T cell targeting vaccine have added benefit?
3) How does site of injection affect systemic vs local immune responses?
tcellvaccineucl.bsky.social
This follow-up used repertoire analysis and functional assays to show
1) T cells were only partially correlated with the protective immunity to SARS-CoV-2.
2) In those with breakthrough infection, T cell responses correlated with less severe symptoms.
A great analysis overall!
tcellvaccineucl.bsky.social
New interesting data on the role of T cells in Ad26-COV2.S-mediated immunity to SARS-CoV-2! Back in 2021, a phase 3 study showed that single dose was able to confer protection from symptomatic COVID-19 and reduced severity of any breakthrough infections.
tcellvaccineucl.bsky.social
We'll be in the City & Guilds Building Exhibition Road, Eureka Zone.
tcellvaccineucl.bsky.social
Great exhibition Road Festival

South Kensington
7 – 8 June 2025
12.00 ⁠–⁠ 18.00
Led by Imperial College London

hundreds of free workshops, performances, talks & interactive exhibits celebrating science & art
Reposted by T cell Vaccines Lab (Swadling UCL) 🧬👩🏽‍🔬
medrxivpreprint.bsky.social
Extensive Intra-host evolution and T cell escape by SARS-CoV-2 in a 2.5-year persistent infection of an immunocompromised host https://www.medrxiv.org/content/10.1101/2025.05.28.25328480v1
tcellvaccineucl.bsky.social
We also have two new students, Priya and Nistha. Priya will be using wet and dry lab work to identify conserved T cell targets in HCoVs for vaccine design, and Nishtha will be studying how varied inhaled vaccines stimulate innate immunity and effects on T cell responses (3/3)
tcellvaccineucl.bsky.social
We're proud to host Dr Xiuyuan Lu from Osaka University as part of the IIT & IFReC exchange programme. She comes with great skills in analysing T cell vaccination responses. We're looking forward to her upcoming talk and of course future collaboration! (2/3)

#UCL #IFReC #vaccine
tcellvaccineucl.bsky.social
Standing room only our recent lab meeting! The group is growing fast, and lots of great science will surely come soon! (1/3)
tcellvaccineucl.bsky.social
(2/2)

My final thought for the day, is that from mechanistic insights or enhancing and developing medicines, it’s exciting to see quantitative research taking increasing space in immunology. Let’s keep the momentum going!

Postdoc Peter, signing off.

#qimmunoday
tcellvaccineucl.bsky.social
(1/2)

Another successful #qimmuno day has drawn to a close, but discussions continue in the pub around the corner! Congrats to the organising committee @qimmuno.bsky.social for an excellent day and to all the speakers for engaging talks.
tcellvaccineucl.bsky.social
(3/3)

Xiaowen Chen was the final presenter, and presented novel research into how we can infer resource competition from dynamic abundance data. A very interesting topic, which has some cool potential overlaps with T and B cell competition for antigens and/or cytokines.

Now for posters!
tcellvaccineucl.bsky.social
(2/3)

Pebs Edwards presented some interesting data on the TCR repertoire in patients with lynch syndrome. A personal highlight for me was the 2 year persistence of neo-antigen clonotypes with apparent subsequent reactivation in at least one patient.
tcellvaccineucl.bsky.social
(1/2)

Final set of talks now. Aubin Ramon started by describing his work to develop NanoMelt for nanobody thermostability assessment. The model uses ensemble learning on just 640 sequences, but accurately predicted Tm in a selection of nanobodies with at least 30% distance from the training set.
tcellvaccineucl.bsky.social
(2/2)

Alastar Phelan then spoke about his mathematical modelling approach to enhance signal detection in dual pulse nucleoside labelling experiments for improving cell cycle analysis.

Both speakers showcased their work really well, armed with only a pen and whiteboard!

#qimmunoday